#OnYourRxSide

Did you know PBMs will negotiate prescription drug costs down by $654 billion over ten years.

Visit the Site

New Research

Rebates are Unrelated to Drugmakers’ Pricing Strategies

View Study

Protect The Savings:

If regulators gut PBM negations from Medicare Part D 3 Things We Know Will Happen

Visit the Site

PCMA Press Releases

OUR NEXT CONFERENCE

PCMA Annual Meeting
September 23 & 24, 2019
Scottsdale, AZ

Join us for the industry’s premier executive conference. The event is tailored specifically for senior executives from PBMs and their affiliated business partners – most notable drug manufacturers.

Learn More

PCMA POLICY & ISSUES

ABOUT OUR INDUSTRY

PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, managed Medicaid plans, and others. PBMs are projected to save employers, unions, government programs, and consumers $654 billion— up to 30 percent—on drug benefit costs over the next decade.

Stay Connected with PCMA!